Alain Moussy | Source | Chief Executive Officer at AB Science
Alain Moussy
Alain Moussy, founder and chief executive officer, Engineer (ENSTA) and MBA Wharton. He is a former strategic consultant at Booz, Allen & Hamilton and former head of corporate development at Carrefour. President of AFIRMM, association of mastocytosis patients.
-
AB Science
Chief Executive Officer
-
AB Science announces that Phase 2B/3 study evaluating oral in Alzheimer’s disease met its primary endpoint
PHASE 2B/3 STUDY EVALUATING MASITINIB IN ALZHEIMER’S DISEASE MET ITS PRIMARY ENDPOINT MASITINIB DEMONSTRATED SIGNIFICANT EFFECT ON BOTH COGNITION,...
Article
-
Neurodegenerative diseases, taken together, represent a huge unmet medical need. We are determined after this third positive study, this time in Alzheimer’s disease, to continue developing masitinib in consultation with health authorities up to registration, in amyotrophic lateral sclerosis, progressive forms of MS and Alzheimer’s disease.
